AN-AZ, Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, CRF, Cell Biology, Cell Signaling and Neuroscience, Neuropeptides, Peptides and Proteins, Peptides for Cell Biology, Pfizer Compounds, Releasing Factors
{SNA} AN-AZ, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index,
{SNA} AN-AZ, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, CRF, Neuropeptides, Peptides and Proteins, Peptides for Cell Biology, Pfizer Compounds, Releasing Factors, 生物活性小分子, 细胞信号转导和神经科学,
相关文献及参考
Zorrilla, E., et al., Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat Brain Res. 952 , 188-199, (2002)
Ducottet, C., et al., Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice Prog. Neuropsychopharmacol. Biol. Psychiatry 27 , 625-631, (2003)
Mello, N., et al., Effects of the CRF1 antagonist antalarmin on cocaine self-administration and discrimination in rhesus monkeys Pharmacol. Biochem. Behav. 85 , 744-751, (2006)
Webster, E.L., et al. Endocrinology 137 , 5747-5750, (1996) 摘要
Young, I.R., et al. Neuroendocrinology 76 , 47-54, (2002) 摘要
安全信息
WGK Germany
3
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter